Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2025)

Mangoceuticals' Return on Capital Employed history spans 3 years, with the latest figure at 1.08% for Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 97.0% year-over-year to 1.08%; the TTM value through Sep 2025 reached 1.08%, down 97.0%, while the annual FY2024 figure was 1.17%, N/A changed from the prior year.
  • Return on Capital Employed for Q3 2025 was 1.08% at Mangoceuticals, down from 0.69% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 3.25% in Q1 2024 and bottomed at 1.74% in Q4 2023.
  • The 3-year median for Return on Capital Employed is 0.6% (2025), against an average of 0.23%.
  • The largest annual shift saw Return on Capital Employed skyrocketed 116bps in 2024 before it crashed -386bps in 2025.
  • A 3-year view of Return on Capital Employed shows it stood at 1.74% in 2023, then surged by 66bps to 0.58% in 2024, then crashed by -85bps to 1.08% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Return on Capital Employed are 1.08% (Q3 2025), 0.69% (Q2 2025), and 0.61% (Q1 2025).